Search Results

17
Results for Allopathy: Vie Rayonnante
    749
    Vie Rayonnante
Imprint -
Contains: Acetylsalicylic acid Diclofenac Furosemide Cinnarizine
    2.04 k
    Vie Rayonnante
Imprint Lisuride is a medication predominantly used for its anti-Parkinson's properties. Classified as a dopamine agonist, it functions by activating dopam...
    13.9 k
    Vie Rayonnante
Imprint Cyclophosphamide is used for chemotherapy and to suppress the immune system. It is used to treat lymphoma, multiple myeloma, leukemia, mycosis fung...
    113
    Vie Rayonnante
Imprint Capecitabine is a medication used in cancer treatment, particularly for breast, colorectal, and gastrointestinal cancers. It belongs to a class of ...
    9.35 k
    Vie Rayonnante
Imprint Semax is a synthetic peptide drug best known for its nootropic, neuroprotective, and neurogenic/neurorestorative properties. It was developed based...
    29.3 k
    Vie Rayonnante
Imprint Adenosine Triphosphate (ATP) can be thought of as the "energetic currency" for life and powers cellular processes. While the body is able to produc...
    11 k
    Vie Rayonnante
Imprint , enhance performance, provide a sense of well-being...
    18.7 k
    Vie Rayonnante
Imprint Insulin-like Growth Factor 1 (IGF-1), also called somatomedin C, is a 70-amino acid polypeptide hormone that is structurally similar to insulin. It...
    5.58 k
    Vie Rayonnante
Imprint compared to DHT. It is being studied for potential use ... managing conditions sensitive to androgens....
    6.05 k
    Vie Rayonnante
Imprint Mebendazole is an anthelmintic medication used to treat various parasitic worm infections. It may help combat a range of intestinal parasites, such...
    127 k
    Vie Rayonnante
Imprint Synthetic delta sleep-inducing peptide is used to treat withdrawal symptoms related to both alcoholism and narcomania. It can also be used to help ...
    13.4 k
    Vie Rayonnante
Imprint seizure activity, combat the effects of dementia, and ... , improve skin quality, strengthen bones, reduce...
Prev 1
Show modal